InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Acumen Pharmaceuticals, Inc.

ABOS Clue Score27
United States Fiscal year ends December CIK 0001576885 Results filed 26 Oct 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Derrell Porter
17 Jun 2026
Director
Sold after exercise
13,040
$2.33
$30.32K
Derrell Porter
15 Jun 2026
Director
Sold after exercise
6,460
$2.35
$15.15K
Derek M Meisner
6 Mar 2026
Chief Legal Officer & Corp Sec
Sold after exercise
2,090
$3.26
$6.81K
Derek M Meisner
27 Feb 2026
Chief Legal Officer & Corp Sec
Sold after exercise
9,406
$3.01
$28.31K
Derek M Meisner
28 Jan 2026
Chief Legal Officer & Corp Sec
Sold after exercise
2,671
$3.00
$8.02K
Derek M Meisner
26 Jan 2026
Chief Legal Officer & Corp Sec
Sold after exercise
15,085
$3.00
$45.26K
Jeffrey L. Ives
17 Aug 2023
Director
Sold after exercise
2,800
$6.66
$18.65K
Jeffrey L. Ives
17 Aug 2023
Director
Sold after exercise
39,149
$6.48
$253.69K
Show all 78 transactions →

What was left out

Form 4 filings counted 120
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 8
Sales at will 42
Transactions with no price 0
Shares from compensation/vesting 30,618,063
History held since 2 Jul 2021